What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, Canada
Ruyu Yan(Centre for Advancing Health Outcomes), Bohdan Nosyk(Simon Fraser University), Sander Greenland(University of California, Los Angeles), Brenda Carolina Guerra‐Alejos(Centre for Advancing Health Outcomes), Jeong Eun Min(Centre for Advancing Health Outcomes), Tom Loughin(Simon Fraser University), Hui Xie(Simon Fraser University), P. Todd Korthuis(Oregon Health & Science University), M. Eugenia Socías(University of British Columbia), Paxton Bach(University of British Columbia), Shaun R. Seaman(Max Planck Society), Evan Wood(University of British Columbia), Kevin Schnepel(Simon Fraser University), Robert W. Platt(McGill University), Lawrence C. McCandless(Simon Fraser University), Megan Kurz(Simon Fraser University), Paul Gustafson, Ehsan Karim(University of British Columbia Hospital)
Cited by 2
Related Papers
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations
|European Journal of Epidemiology|2016|3.1k
Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies
|Epidemiology|2009|1.9k
Multiple Sclerosis Severity Score
|Neurology|2005|959
Sparse data bias: a problem hiding in plain sight
|BMJ|2016|868
Illustrating bias due to conditioning on a collider
|International Journal of Epidemiology|2009|821